1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage/Taxonomy
2.2. Market Definition/Scope/Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. Value Chain Analysis
3.5.1. Profit Margin Analysis
3.5.2. Service Providers
3.6. PESTLE and Porter’s Analysis
3.7. Regulatory Landscape
3.7.1. By Key Regions
3.7.2. By Key Countries
3.8. Regional Parent Market Outlook
4. Global Breast Reconstruction Surgery and Treatment Market Analysis 2017-2021 and Forecast, 2022-2032
4.1. Historical Market Size Value (US$ Mn) Analysis, 2017-2021
4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Breast Reconstruction Surgery and Treatment Market Analysis 2017-2021 and Forecast 2022-2032, By Product
5.1. Introduction/Key Findings
5.2. Historical Market Size Value (US$ Mn) Analysis By Product, 2017-2021
5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Product, 2022-2032
5.3.1. Breast Implants
5.3.1.1. Silicone Implants
5.3.1.2. Saline Implants
5.3.1.3. Round Implants
5.3.1.4. Anatomical Implants
5.3.2. Tissue Expanders
5.3.3. Acellular Dermal Matrix
5.4. Y-o-Y Growth Trend Analysis By Product, 2017-2021
5.5. Absolute $ Opportunity Analysis By Product, 2022-2032
6. Global Breast Reconstruction Surgery and Treatment Market Analysis 2017-2021 and Forecast 2022-2032, By Procedure
6.1. Introduction/Key Findings
6.2. Historical Market Size Value (US$ Mn) Analysis By Procedure, 2017-2021
6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Procedure, 2022-2032
6.3.1. Immediate
6.3.2. Delayed
6.3.3. Revision
6.4. Y-o-Y Growth Trend Analysis By Procedure, 2017-2021
6.5. Absolute $ Opportunity Analysis By Procedure, 2022-2032
7. Global Breast Reconstruction Surgery and Treatment Market Analysis 2017-2021 and Forecast 2022-2032, By Type
7.1. Introduction/Key Findings
7.2. Historical Market Size Value (US$ Mn) Analysis By Type, 2017-2021
7.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Type, 2022-2032
7.3.1. Unilateral
7.3.2. Bilateral
7.4. Y-o-Y Growth Trend Analysis By Type, 2017-2021
7.5. Absolute $ Opportunity Analysis By Type, 2022-2032
8. Global Breast Reconstruction Surgery and Treatment Market Analysis 2017-2021 and Forecast 2022-2032, By End User
8.1. Introduction/Key Findings
8.2. Historical Market Size Value (US$ Mn) Analysis By End User, 2017-2021
8.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By End User, 2022-2032
8.3.1. Hospitals
8.3.2. Cosmetology Clinics and Ambulatory Surgical Centers
8.4. Y-o-Y Growth Trend Analysis By End User, 2017-2021
8.5. Absolute $ Opportunity Analysis By End User, 2022-2032
9. Global Breast Reconstruction Surgery and Treatment Market Analysis 2017-2021 and Forecast 2022-2032, By Region
9.1. Introduction
9.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2017-2021
9.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032
9.3.1. North America
9.3.2. Latin America
9.3.3. Europe
9.3.4. Asia Pacific
9.3.5. MEA
9.4. Market Attractiveness Analysis By Region
10. North America Breast Reconstruction Surgery and Treatment Market Analysis 2017-2021 and Forecast 2022-2032, By Country
10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
10.2.1. By Country
10.2.1.1. U.S.
10.2.1.2. Canada
10.2.2. By Product
10.2.3. By Procedure
10.2.4. By Type
10.2.5. By End User
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Product
10.3.3. By Procedure
10.3.4. By Type
10.3.5. By End User
10.4. Key Takeaways
11. Latin America Breast Reconstruction Surgery and Treatment Market Analysis 2017-2021 and Forecast 2022-2032, By Country
11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
11.2.1. By Country
11.2.1.1. Brazil
11.2.1.2. Mexico
11.2.1.3. Argentina
11.2.1.4. Chile
11.2.1.5. Peru
11.2.1.6. Rest of Latin America
11.2.2. By Product
11.2.3. By Procedure
11.2.4. By Type
11.2.5. By End User
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Product
11.3.3. By Procedure
11.3.4. By Type
11.3.5. By End User
11.4. Key Takeaways
12. Europe Breast Reconstruction Surgery and Treatment Market Analysis 2017-2021 and Forecast 2022-2032, By Country
12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
12.2.1. By Country
12.2.1.1. Germany
12.2.1.2. Italy
12.2.1.3. France
12.2.1.4. U.K.
12.2.1.5. Spain
12.2.1.6. Russia
12.2.1.7. BENELUX
12.2.1.8. Rest of Europe
12.2.2. By Product
12.2.3. By Procedure
12.2.4. By Type
12.2.5. By End User
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Product
12.3.3. By Procedure
12.3.4. By Type
12.3.5. By End User
12.4. Key Takeaways
13. Asia Pacific Breast Reconstruction Surgery and Treatment Market Analysis 2017-2021 and Forecast 2022-2032, By Country
13.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
13.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
13.2.1. By Country
13.2.1.1. China
13.2.1.2. Japan
13.2.1.3. South Korea
13.2.1.4. Rest of Asia Pacific
13.2.2. By Product
13.2.3. By Procedure
13.2.4. By Type
13.2.5. By End User
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Product
13.3.3. By Procedure
13.3.4. By Type
13.3.5. By End User
13.4. Key Takeaways
14. MEA Breast Reconstruction Surgery and Treatment Market Analysis 2017-2021 and Forecast 2022-2032, By Country
14.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
14.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
14.2.1. By Country
14.2.1.1. GCC Countries
14.2.1.2. South Africa
14.2.1.3. Turkey
14.2.1.4. Rest of MEA
14.2.2. By Product
14.2.3. By Procedure
14.2.4. By Type
14.2.5. By End User
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Product
14.3.3. By Procedure
14.3.4. By Type
14.3.5. By End User
14.4. Key Takeaways
15. Key Countries Breast Reconstruction Surgery and Treatment Market Analysis
15.1. U.S.
15.1.1. Pricing Analysis
15.1.2. Market Share Analysis, 2021
15.1.2.1. By Product
15.1.2.2. By Procedure
15.1.2.3. By Type
15.1.2.4. By End User
15.2. Canada
15.2.1. Pricing Analysis
15.2.2. Market Share Analysis, 2021
15.2.2.1. By Product
15.2.2.2. By Procedure
15.2.2.3. By Type
15.2.2.4. By End User
15.3. Brazil
15.3.1. Pricing Analysis
15.3.2. Market Share Analysis, 2021
15.3.2.1. By Product
15.3.2.2. By Procedure
15.3.2.3. By Type
15.3.2.4. By End User
15.4. Mexico
15.4.1. Pricing Analysis
15.4.2. Market Share Analysis, 2021
15.4.2.1. By Product
15.4.2.2. By Procedure
15.4.2.3. By Type
15.4.2.4. By End User
15.5. Argentina
15.5.1. Pricing Analysis
15.5.2. Market Share Analysis, 2021
15.5.2.1. By Product
15.5.2.2. By Procedure
15.5.2.3. By Type
15.5.2.4. By End User
15.6. Chile
15.6.1. Pricing Analysis
15.6.2. Market Share Analysis, 2021
15.6.2.1. By Product
15.6.2.2. By Procedure
15.6.2.3. By Type
15.6.2.4. By End User
15.7. Peru
15.7.1. Pricing Analysis
15.7.2. Market Share Analysis, 2021
15.7.2.1. By Product
15.7.2.2. By Procedure
15.7.2.3. By Type
15.7.2.4. By End User
15.8. Germany
15.8.1. Pricing Analysis
15.8.2. Market Share Analysis, 2021
15.8.2.1. By Product
15.8.2.2. By Procedure
15.8.2.3. By Type
15.8.2.4. By End User
15.9. Italy
15.9.1. Pricing Analysis
15.9.2. Market Share Analysis, 2021
15.9.2.1. By Product
15.9.2.2. By Procedure
15.9.2.3. By Type
15.9.2.4. By End User
15.10. France
15.10.1. Pricing Analysis
15.10.2. Market Share Analysis, 2021
15.10.2.1. By Product
15.10.2.2. By Procedure
15.10.2.3. By Type
15.10.2.4. By End User
15.11. U.K.
15.11.1. Pricing Analysis
15.11.2. Market Share Analysis, 2021
15.11.2.1. By Product
15.11.2.2. By Procedure
15.11.2.3. By Type
15.11.2.4. By End User
15.12. Spain
15.12.1. Pricing Analysis
15.12.2. Market Share Analysis, 2021
15.12.2.1. By Product
15.12.2.2. By Procedure
15.12.2.3. By Type
15.12.2.4. By End User
15.13. Russia
15.13.1. Pricing Analysis
15.13.2. Market Share Analysis, 2021
15.13.2.1. By Product
15.13.2.2. By Procedure
15.13.2.3. By Type
15.13.2.4. By End User
15.14. BENELUX
15.14.1. Pricing Analysis
15.14.2. Market Share Analysis, 2021
15.14.2.1. By Product
15.14.2.2. By Procedure
15.14.2.3. By Type
15.14.2.4. By End User
15.15. China
15.15.1. Pricing Analysis
15.15.2. Market Share Analysis, 2021
15.15.2.1. By Product
15.15.2.2. By Procedure
15.15.2.3. By Type
15.15.2.4. By End User
15.16. Japan
15.16.1. Pricing Analysis
15.16.2. Market Share Analysis, 2021
15.16.2.1. By Product
15.16.2.2. By Procedure
15.16.2.3. By Type
15.16.2.4. By End User
15.17. South Korea
15.17.1. Pricing Analysis
15.17.2. Market Share Analysis, 2021
15.17.2.1. By Product
15.17.2.2. By Procedure
15.17.2.3. By Type
15.17.2.4. By End User
15.18. GCC Countries
15.18.1. Pricing Analysis
15.18.2. Market Share Analysis, 2021
15.18.2.1. By Product
15.18.2.2. By Procedure
15.18.2.3. By Type
15.18.2.4. By End User
15.19. South Africa
15.19.1. Pricing Analysis
15.19.2. Market Share Analysis, 2021
15.19.2.1. By Product
15.19.2.2. By Procedure
15.19.2.3. By Type
15.19.2.4. By End User
15.20. Turkey
15.20.1. Pricing Analysis
15.20.2. Market Share Analysis, 2021
15.20.2.1. By Product
15.20.2.2. By Procedure
15.20.2.3. By Type
15.20.2.4. By End User
16. Market Structure Analysis
16.1. Competition Dashboard
16.2. Competition Benchmarking
16.3. Market Share Analysis of Top Players
16.3.1. By Regional
16.3.2. By Product
16.3.3. By Procedure
16.3.4. By Type
16.3.5. By End User
17. Competition Analysis
17.1. Competition Deep Dive
17.1.1. Mentor Worldwide LLC (Johnson & Johnson)
17.1.1.1. Overview
17.1.1.2. Product Portfolio
17.1.1.3. Profitability by Market Segments
17.1.1.4. Sales Footprint
17.1.1.5. Strategy Overview
17.1.1.5.1. Marketing Strategy
17.1.1.5.2. Product Strategy
17.1.1.5.3. Channel Strategy
17.1.2. Allergan Aesthetics (An AbbVie Company)
17.1.2.1. Overview
17.1.2.2. Product Portfolio
17.1.2.3. Profitability by Market Segments
17.1.2.4. Sales Footprint
17.1.2.5. Strategy Overview
17.1.2.5.1. Marketing Strategy
17.1.2.5.2. Product Strategy
17.1.2.5.3. Channel Strategy
17.1.3. Sientra
17.1.3.1. Overview
17.1.3.2. Product Portfolio
17.1.3.3. Profitability by Market Segments
17.1.3.4. Sales Footprint
17.1.3.5. Strategy Overview
17.1.3.5.1. Marketing Strategy
17.1.3.5.2. Product Strategy
17.1.3.5.3. Channel Strategy
17.1.4. POLYTECH Health & Aesthetics GmbH
17.1.4.1. Overview
17.1.4.2. Product Portfolio
17.1.4.3. Profitability by Market Segments
17.1.4.4. Sales Footprint
17.1.4.5. Strategy Overview
17.1.4.5.1. Marketing Strategy
17.1.4.5.2. Product Strategy
17.1.4.5.3. Channel Strategy
17.1.5. GC Aesthetics
17.1.5.1. Overview
17.1.5.2. Product Portfolio
17.1.5.3. Profitability by Market Segments
17.1.5.4. Sales Footprint
17.1.5.5. Strategy Overview
17.1.5.5.1. Marketing Strategy
17.1.5.5.2. Product Strategy
17.1.5.5.3. Channel Strategy
17.1.6. Sebbin
17.1.6.1. Overview
17.1.6.2. Product Portfolio
17.1.6.3. Profitability by Market Segments
17.1.6.4. Sales Footprint
17.1.6.5. Strategy Overview
17.1.6.5.1. Marketing Strategy
17.1.6.5.2. Product Strategy
17.1.6.5.3. Channel Strategy
17.1.7. Establishment Labs S.A.
17.1.7.1. Overview
17.1.7.2. Product Portfolio
17.1.7.3. Profitability by Market Segments
17.1.7.4. Sales Footprint
17.1.7.5. Strategy Overview
17.1.7.5.1. Marketing Strategy
17.1.7.5.2. Product Strategy
17.1.7.5.3. Channel Strategy
17.1.8. Integra LifeSciences
17.1.8.1. Overview
17.1.8.2. Product Portfolio
17.1.8.3. Profitability by Market Segments
17.1.8.4. Sales Footprint
17.1.8.5. Strategy Overview
17.1.8.5.1. Marketing Strategy
17.1.8.5.2. Product Strategy
17.1.8.5.3. Channel Strategy
17.1.9. RTI Surgical Holdings
17.1.9.1. Overview
17.1.9.2. Product Portfolio
17.1.9.3. Profitability by Market Segments
17.1.9.4. Sales Footprint
17.1.9.5. Strategy Overview
17.1.9.5.1. Marketing Strategy
17.1.9.5.2. Product Strategy
17.1.9.5.3. Channel Strategy
17.1.10. Ideal Implant Incorporated
17.1.10.1. Overview
17.1.10.2. Product Portfolio
17.1.10.3. Profitability by Market Segments
17.1.10.4. Sales Footprint
17.1.10.5. Strategy Overview
17.1.10.5.1. Marketing Strategy
17.1.10.5.2. Product Strategy
17.1.10.5.3. Channel Strategy
17.1.11. Laboratoires Arion
17.1.11.1. Overview
17.1.11.2. Product Portfolio
17.1.11.3. Profitability by Market Segments
17.1.11.4. Sales Footprint
17.1.11.5. Strategy Overview
17.1.11.5.1. Marketing Strategy
17.1.11.5.2. Product Strategy
17.1.11.5.3. Channel Strategy
17.1.12. Silimed
17.1.12.1. Overview
17.1.12.2. Product Portfolio
17.1.12.3. Profitability by Market Segments
17.1.12.4. Sales Footprint
17.1.12.5. Strategy Overview
17.1.12.5.1. Marketing Strategy
17.1.12.5.2. Product Strategy
17.1.12.5.3. Channel Strategy
17.1.13. Guangzhou Wanhe Plastic Materials Co., Ltd.
17.1.13.1. Overview
17.1.13.2. Product Portfolio
17.1.13.3. Profitability by Market Segments
17.1.13.4. Sales Footprint
17.1.13.5. Strategy Overview
17.1.13.5.1. Marketing Strategy
17.1.13.5.2. Product Strategy
17.1.13.5.3. Channel Strategy
17.1.14. Céréplas
17.1.14.1. Overview
17.1.14.2. Product Portfolio
17.1.14.3. Profitability by Market Segments
17.1.14.4. Sales Footprint
17.1.14.5. Strategy Overview
17.1.14.5.1. Marketing Strategy
17.1.14.5.2. Product Strategy
17.1.14.5.3. Channel Strategy
17.1.15. Hansbiomed
17.1.15.1. Overview
17.1.15.2. Product Portfolio
17.1.15.3. Profitability by Market Segments
17.1.15.4. Sales Footprint
17.1.15.5. Strategy Overview
17.1.15.5.1. Marketing Strategy
17.1.15.5.2. Product Strategy
17.1.15.5.3. Channel Strategy
17.1.16. PMT Corporation
17.1.16.1. Overview
17.1.16.2. Product Portfolio
17.1.16.3. Profitability by Market Segments
17.1.16.4. Sales Footprint
17.1.16.5. Strategy Overview
17.1.16.5.1. Marketing Strategy
17.1.16.5.2. Product Strategy
17.1.16.5.3. Channel Strategy
17.1.17. PFM Medical
17.1.17.1. Overview
17.1.17.2. Product Portfolio
17.1.17.3. Profitability by Market Segments
17.1.17.4. Sales Footprint
17.1.17.5. Strategy Overview
17.1.17.5.1. Marketing Strategy
17.1.17.5.2. Product Strategy
17.1.17.5.3. Channel Strategy
